Company Profiles

driven by the PitchBook Platform

Impel NeuroPharma

Description

Developer of next generation therapeutics designed to offer intranasal drug treatments for central nervous system (CNS) disorders. The company's next generation therapeutics uses novel drug delivery platform and nasal devices for improved bio-distribution, bio-availability and decreased dose-to-dose variability of small molecules and biologic drugs.

2008

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$36M

Latest Deal Amount

$45.1M

Total Amount Raised

Description

Developer of next generation therapeutics designed to offer intranasal drug treatments for central nervous system (CNS) disorders. The company's next generation therapeutics uses novel drug delivery platform and nasal devices for improved bio-distribution, bio-availability and decreased dose-to-dose variability of small molecules and biologic drugs.

Website:

www.impelnp.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Medical Supplies

Other Industries

Therapeutic Devices
Drug Delivery

Primary Office

915 East Pine Street Suite 404 Seattle, WA 98122United States +1 (206) 568-1466
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Impel NeuroPharma's full profile, request a free trial.

Impel NeuroPharma Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Impel NeuroPharma Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Impel NeuroPharma Investors (8)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
3M New VenturesCorporate Venture CapitalMinority000 0000000 0000
5AM VenturesVenture CapitalMinority000 0000000 0000
Alliance of AngelsAngel GroupMinority000 0000000 0000
Life Science Discovery FundVenture CapitalMinority000 0000000 0000
The Washington Medical Technology Angel NetworkAngel GroupMinority000 0000000 0000
3M New Ventures Corporate Venture Capital
5AM Ventures Venture Capital
Alliance of Angels Angel Group
Life Science Discovery Fund Venture Capital
The Washington Medical Technology Angel Network Angel Group

Impel NeuroPharma Executive Team (8)

NameTitleBoard
Seat
Contact
Info
John Hoekman Ph.DCo-Founder, Board Member & Interim Chief Executive Officer
Paul Jenkins Ph.DDirector, Business Development
Nyssa LiebermannExecutive
Michael HiteCo-Founder
Scott YoumansSenior Vice President, Engineering
John Hoekman Ph.D Co-Founder, Board Member & Interim Chief Executive Officer
Paul Jenkins Ph.D Director, Business Development
Nyssa Liebermann Executive
Michael Hite Co-Founder
Scott Youmans Senior Vice President, Engineering

Impel NeuroPharma Board Members (5)

NameRepresentingRoleSinceContact
Info
Aaron Royston MDvenBioPrincipal000 0000
James Young Ph.D5AM VenturesVenture Partner000 0000
Mahendra Shah Ph.DSelfBoard Member000 0000
Perry Fell Ph.DSelfBoard Member000 0000
Timothy NelsonSelfIndependent Director000 0000
Aaron Royston MD Principal venBio
James Young Ph.D Venture Partner 5AM Ventures
Mahendra Shah Ph.D Board Member Self
Perry Fell Ph.D Board Member Self
Timothy Nelson Independent Director Self
Request full access to PitchBook